Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
- Expanded Access of SotorasibNo Longer Available
Sponsor: Amgen
Non Small-cell Lung Cancer · Locally Advanced Unresectable NSCLC · Locally Advanced Metastatic NSCLC
United States, Argentina, Brazil, Israel, Saudi Arabia +1 more
- A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung CancerRecruiting
Sponsor: Mayo Clinic
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States
Sponsor: Cybrexa Therapeutics
Solid Tumor, Adult · Epithelial Ovarian Cancer · Small Cell Lung Carcinoma · Breast Cancer
United States
- A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +23 more
- Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II TrialNot Yet Recruiting
Sponsor: Sichuan Cancer Hospital and Research Institute
Non-Small Cell Lung Cancer
China
Sponsor: National Cancer Institute (NCI)
Advanced Lung Neuroendocrine Tumor · Functioning Lung Neuroendocrine Tumor · Locally Advanced Lung Neuroendocrine Neoplasm · Lung Neuroendocrine Neoplasm
United States
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Non-Small Cell Lung Cancer
China
Sponsor: Regeneron Pharmaceuticals
Cancer-Associated Thrombosis (CAT)
United States, Georgia, Japan
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
Spain
- OPTIMISE Lung SABRNot Yet Recruiting
Sponsor: Cancer Trials Ireland
Non Small Cell Lung Cancer
Ireland
Sponsor: Revolution Medicines, Inc.
NSCLC · Non-small Cell Lung Cancer · Non-Small Cell Lung Cancer NSCLC · Non-Squamous Non Small Cell Lung Cancer
United States
- A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung CancerRecruiting
Sponsor: M.D. Anderson Cancer Center
Non-Small Cell Lung Cancer · ICI-refractory
United States
- LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung CancerNot Yet Recruiting
Sponsor: Medical University of South Carolina
Survivorship
- Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentActive Not Recruiting
Sponsor: Boehringer Ingelheim
Lung Cancer, Non-squamous, Non-small Cell
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma
United States
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsActive Not Recruiting
Sponsor: Pfizer
Liposarcoma · Prostate Cancer · Breast Neoplasms · Adenocarcinoma of Lung
United States, Argentina, China, Czechia, Japan +3 more
- Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide PolymorphismsActive Not Recruiting
Sponsor: Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair
ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
United States
Sponsor: Brown University
Non Small Cell Lung Cancer
United States
Sponsor: Vanderbilt-Ingram Cancer Center
Lung Cancer
United States
- Neuroendocrine Tumors - Patient Reported OutcomesActive Not Recruiting
Sponsor: University of Iowa
Neuroendocrine Tumors · Gastroenteropancreatic Neuroendocrine Tumor · Lung Neuroendocrine Neoplasm · Neuroendocrine Carcinoma
United States
Sponsor: Kaiser Permanente
Advanced Colorectal Carcinoma · Advanced Lung Non-Small Cell Carcinoma · Advanced Pancreatic Adenocarcinoma · Stage IV Colorectal Cancer AJCC v8
United States
- CINC424A2X01B Rollover ProtocolActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis · Polycythemia Vera · Graft Versus Host Disease · Acute Myeloid Leukemia
Australia, Belgium, Bulgaria, Canada, Chile +20 more
Sponsor: AstraZeneca
Non-squamous Metastatic Non-Small-Cell Lung Carcinoma
Germany
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Lung Disease · Pneumothorax · Tuberous Sclerosis · Lymphangioleiomyomatosis
United States
- [18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer.Active Not Recruiting
Sponsor: Amsterdam UMC, location VUmc
Non-Small Cell Lung Cancer
Netherlands